AUSTIN LEE: Open Payments
NPI 1851769491 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,792 in 87 payments from 15 companies in 2025. Trend: 2023 $1,974 · 2024 $1,223 · 2025 $1,792
Food & beverage: $1,622Education: $170
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $527 |
| Organon LLC | 16 | $251 |
| Galderma Laboratories, L.P. | 15 | $201 |
| Novartis Pharmaceuticals Corporation | 12 | $181 |
| ABBVIE INC. | 10 | $163 |
| GENZYME CORPORATION | 3 | $91 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Kerecis Limited | 1 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $50 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, VTAMA, SKYRIZI, COSENTYX, Rhapsido, Kerecis SurgiClose.
Industry payments across ID — which companies pay providers there.
